JAGX James J Bochnowski buys $0 worth of shares
Apr 03, 2025, 4:33 AM
0.00%
What does JAGX do
Jaguar Health, a San Francisco-based pharmaceutical company with 49 employees, specializes in plant-derived medicines for gastrointestinal issues in humans and animals, including Mytesi for HIV patients and Canalevia-CA1 for dogs. The company went public on May 13, 2015, and operates through human and animal health segments.
James J Bochnowski bought 54,004 shares of JAGX on 31 March at $0.00 per share, worth a total of $0. They now own 27,002 JAGX shares, or a 200% holding increase.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
